Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2023-06-20 00:00:00 ET · period of report 2023-06-20 · accession 0001127602-23-018978 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-06-20 | 2023-06-20 | LXRX | WADE JEFFREY L | Pres, CFO | P - Purchase | $2.34 | +12.0K | 252.3K | +5% | +$28.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-20 | P | A | 2,000 | $2.33 | 254,341 | D | — | — | |
| 2 | Common | Common Stock | 2023-06-20 | P | A | 10,000 | $2.34 | 252,341 | D | — | — |